Known targets — ChEMBL curated mechanism
SLC6A2SLC6A3SSTR1SSTR2SSTR3SSTR5
The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.37 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.37 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.37 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.37 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aspartic Acid SCHEMBL888096 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL28476128 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL27865040 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL5195845 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL5160188 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL1846849 | 0.97 | SLC22A6 (0.38) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL1987594 | 0.97 | SLC22A6 (0.41) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL518279 | 0.95 | SLC22A6 (0.39) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL11903450 | 0.95 | SLC22A6 (0.39) | SLC22A6GABRR1LMNATDP1GRIK1 | |
| Aspartic Acid SCHEMBL120544 | 0.95 | SLC22A6 (0.39) | SLC22A6GABRR1LMNATDP1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2710 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122004003-A | Method for improving saline-alkali soil by synergistic effect of salt-tolerant microbial inoculum and fertilizer | 轮台县史丹利化肥有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12582149-B1 | Functional additive for hot beverages and foods | MILJKOVIC IGOR (US) | 2026-03-24 | — | — | US | claimed |
| US-12491224-B2 | Composition for hydration and reducing the effects of acohol | Manna Health LLC (US) | 2025-12-09 | — | — | US | claimed |
| US-20250367169-A1 | FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT | FAETH THERAPEUTICS INC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250345362-A1 | MULTI-IONIC COMPLEX FOR THE PREVENTION OR TREATMENT OF INFLAMMATION | YNIOS PHARMA (BE) | 2025-11-13 | — | — | US | claimed |
| US-20250145919-A1 | ELECTROLYTE ENHANCED SPIRITS AND METHOD FOR THE PRODUCTION OF ELECTROLYTE ENHANCED SPIRITS | Llyte, LLC D/B/A Lytos Vodka | 2025-05-08 | — | — | US | claimed |
| WO-2025061694-A1 | BIOCOMPATIBLE AND INJECTABLE PHOTOVOLTAIC RETINAL PROSTHESIS | AARHUS UNIVERSITET (DK) | 2025-03-27 | — | — | WO | claimed |
| US-20250098697-A1 | PROCESS TO BIND NUTRIENTS OR MINERALS TO COFFEE | ELECTROBREW INC (US) | 2025-03-27 | — | — | US | claimed |
| US-5770762-A | Process for producing 4-substituted-2-butenals | KURARAY CO., LTD. (JP) | 1998-06-23 | — | — | US | claimed |
| US-5702691-A | Flavanonol derivatives and hair-nourishing, hair growing compositions containing the derivatives | KAO CORPORATION (JP) | 1997-12-30 | — | — | US | claimed |
| EP-0803493-A2 | Process for producing 4-substituted-2-butenals | KURARAY CO., LTD. (JP) | 1997-10-29 | — | — | EP | claimed |
| US-5460944-A | Conjugate of peroxidase and immunologically bindable substance organic buffer and aspartate salt | BOEHRINGER MANNHEIM GMBH (DE) | 1995-10-24 | — | — | US | claimed |
| EP-0573466-A1 | DIETETIC OR PHARMACEUTICAL COMPOSITIONS FOR THE RESTORATION OF ADENINE NUCLEOTIDE CELL CONTENT IN SKELETAL AND CARDIAC MUSCLES. | DEPHA TEAM SRL (IT) | 1993-12-15 | — | — | EP | claimed |
| US-5162378-A | Cetyl dimethicone copolyol, water, silicone, and alcohol; moisturizer, antiperspirant | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1992-11-10 | — | — | US | claimed |
| WO-1992015311-A1 | DIETETIC OR PHARMACEUTICAL COMPOSITIONS FOR THE RESTORATION OF ADENINE NUCLEOTIDE CELL CONTENT IN SKELETAL AND CARDIAC MUSCLES | DEPHA TEAM S.R.L. (IT) | 1992-09-17 | — | — | WO | claimed |
| US-4738856-A | Beverage and method for making a beverage for the nutritional supplementation of calcium in humans | NUTRITION TECHNOLOGIES, INC. (US) | 1988-04-19 | — | — | US | claimed |
| EP-0246177-A2 | A beverage and method for making a beverage for the nutritional supplementation of calcium in humans | Clark, George H. (US) | 1987-11-19 | — | — | EP | claimed |
| EP-0202106-A2 | A beverage and method of making a beverage for the replacement of body fluids and electrolytes | Clark, George H. (US) | 1986-11-20 | — | — | EP | claimed |